I’m Not Just Being Stubborn: Rest Is Hard for Me

IPF May Have a Specific Gene Signature, Aiding Potential New Therapies, Analysis Finds

Researchers have identified 39 genes as critical to idiopathic pulmonary fibrosis (IPF), based on a computational analysis of large genomic studies. Their study, “Detecting the Molecular System Signatures of Idiopathic Pulmonary Fibrosis through Integrated Genomic Analysis,” appeared in the journal Scientific Reports. IPF patients do not respond to anti-inflammatory therapies such…

What Is a ‘Spoonie’?

https://www.youtube.com/watch?v=n2YQ3H4XT3c If you’re active on the Internet, particularly in groups and forums regarding chronic illness, you’ve definitely noticed the term “spoonie” being thrown around. MORE: While there is currently no known cure for IPF, there are treatments available to help ease the symptoms. Spoonie is a…

7 Common Questions About Esbriet

Esbriet (pirfenidone) is an anti-fibrotic and anti-inflammatory drug used in the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF). Manufactured by Genentech and given FDA approval in 2014, the drug reduces the amount of lung fibrosis by blocking secretions responsible for excessive collagen production. It also reduces inflammation in the lungs.